Cryoport, Inc. (CYRX)

↓ Download CSV

CIK 0001124524 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Dec 31

In fiscal 2025, Cryoport, Inc. reported revenue of $176.18M, up 12.4% from the prior year. The company was profitable, with a net margin of 44.4% and a gross margin of 47.1%. It held $764.99M in total assets against $262.35M in total liabilities.

Key ratios (FY2025)

47.1%
Gross margin
-20.9%
Operating margin
44.4%
Net margin
15.6%
Return on equity
+12.4%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$176.18M$156.77M$168.66M$237.28M$222.61M$78.70M$33.94M$19.63M$11.95M
Cost of Revenue$93.12M$87.11M$93.33M$133.40M$126.03M$42.36M$16.59M$9.39M$5.99M$4.58M
Gross Profit$83.05M$69.66M$75.33M$103.87M$96.58M$36.33M$17.35M$10.24M$5.97M$3.10M
Operating Income-$36.81M-$121.67M-$100.54M-$31.90M-$17.83M-$30.01M-$17.68M-$8.64M-$7.89M-$8.77M
Net Income$78.30M-$114.76M-$99.59M-$37.33M-$275.53M-$32.69M-$18.33M-$9.56M-$7.90M-$13.11M
EPS (Diluted)$1.40$-2.49$-2.21$-0.93$-6.18$-1.94$-0.55
Total Assets$764.99M$703.49M$957.74M$1.04B$1.11B$552.40M$135.87M$56.62M$20.26M$8.11M
Total Liabilities$262.35M$301.59M$468.72M$482.91M$471.14M$169.71M$9.59M$18.07M$2.38M$2.43M
Shareholders' Equity$502.64M$401.90M$489.02M$555.84M$641.83M$382.70M$126.28M$38.55M$17.89M$5.68M
Cash & Equivalents$250.49M$34.14M$35.19M$29.23M$139.10M$36.87M$47.23M$37.33M$15.04M$4.52M
Operating Cash Flow-$8.58M-$16.32M-$757.0K-$1.85M$8.13M-$14.87M-$1.32M-$3.35M-$3.58M-$5.72M
Capital Expenditures$16.44M$17.25M$38.78M$22.11M$23.88M$8.92M$5.34M$2.91M$1.71M$1.06M
Shares Outstanding49.85M49.91M48.97M48.33M49.62M39.84M37.34M30.32M25.70M17.60M